Skip to main content

Month: November 2024

Sampo plc’s share buybacks 28 November 2024

Sampo plc, stock exchange release, 29 November 2024 at 8:30 am EET Sampo plc’s share buybacks 28 November 2024 On 28 November 2024, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  2,959 40.57 AQEU          39,666 40.57 CEUX  271 40.52 TQEX  49,904 40.58 XHELTOTAL 92,800 40.58  *rounded to two decimals                 On 17 June 2024, Sampo announced a share buyback programme of up to a maximum of EUR 400 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. On 16 September 2024, the Board of Directors...

Continue reading

Cera and KBC Ancora extend their KBC Group ‘anchoring agreement’

Regulated information, 29 November 2024 (07.30 CET) Cera and KBC Ancora extend their KBC Group ‘anchoring agreements’ Leuven, 29 November 2024 (07.30 CET) – Cera and KBC Ancora, together with MRBB and the Other Stable Shareholders, have confirmed to extend unchanged their anchoring agreement with respect to KBC Group for a further term of ten years. Rooted in a shared long-term vision, this extension means that the shareholders concerned will continue to ensure the shareholder stability and support the further development of the KBC group.Cera and KBC Ancora extend their KBC Group ‘anchoring agreements’ Together with MRBB and the Other Stable Shareholders, Cera and KBC Ancora ensure the shareholder stability and further development of the KBC group. To this end, on 23 December 2004, these parties entered...

Continue reading

Martin Engell-Rossen will be Head of Cabinet to Denmark’s new EU Commissioner Dan Jørgensen in Brussels and will therefore resign from the Board of Directors of Pharma Equity Group A/S

        29 November 2024Announcement No. 31   Martin Engell-Rossen will be Head of Cabinet to Denmark’s new EU Commissioner Dan Jørgensen in Brussels and will therefore resign from the Board of Directors of Pharma Equity Group A/S.   Martin Engell-Rossen has informed Pharma Equity Group that he is leaving the Board of Directors of the Company.   Mette Frederiksen’s former adviser, Martin Engell-Rossen, will be head of cabinet for Denmark’s new EU commissioner, Dan Jørgensen, in Brussels. Quite naturally, this necessarily means a farewell to the board position in Pharma Equity Group.   Since Martin Engell-Rossen joined the Board of Directors on 2 November 2023, he has contributed with his knowledge of strategic communication and worked to strengthen Pharma Equity Group’s visibility and...

Continue reading

Unaudited information of Invalda INVL group for 9 months of 2024

Invalda INVL, the leading Baltic asset management group, had equity of EUR 202.5 million at the end of September this year, or EUR 16.85 per share. Those figures were 50.2% and 50.1% larger, respectively, than a year earlier, including the dividends paid this year. In January-September 2024, Invalda INVL earned an unaudited net profit of EUR 25.8 million, an increase of 7.1 times compared to the same period last year, when the net profit was EUR 3.6 million. “The situation remains tense, both globally and in the region where we operate directly. Despite this, the third quarter was successful for the investments we manage, generating profits for our clients,” says Darius Šulnis, CEO of Invalda INVL. The value of client assets under management by the group’s companies grew to EUR 1.66 billion at the end of September 2024 and was up 15.3%...

Continue reading

Pluxee acquires Beneficio Facil in Brazil and reinforces its employee mobility offer

Pluxee acquires Benefício Fácil in Brazil and reinforces its employee mobility offer Pluxee to reinforce its strong position in Brazil by acquiring 100% of Benefício Fácil, a Brazilian provider of employee mobility benefits Transaction accretive to Recurring EBITDA margin at Group level from the first year Operation to be fully funded from existing financial resourcesParis: November 29, 2024 // Pluxee (the “Group”), a global player in Employee Benefits and Engagement, today announces that it has signed an agreement to acquire 100% of Benefício Fácil, a provider of mobility solutions for public transport in Brazil, a growing and underpenetrated market in which mobility benefits for employees are mandatory. The agreement is subject to approval from the Central Bank of Brazil (BACEN). With this new acquisition, Pluxee continues to deliver...

Continue reading

Net asset value of the EfTEN United Property Fund as of 31.10.2024

In October, EfTEN United Property Fund announced an income distribution of 142 thousand euros, which was paid out to investors on November 14. As a result, the fund’s net asset value (NAV) increased by 0.2% in October to 10.70 euros. Excluding the cash distribution, EfTEN United Property Fund’s NAV would have increased by 0.6% in October. In October, the average interest rate on the fund’s liabilities decreased by 50 basis points to 5.6%. The sharp decrease was related to the decrease in EURIBOR and the renewal of the Uus-Järveküla residential development loan agreement on more favorable terms. In November, EfTEN United Property Fund announced a planned investment in the EfTEN Real Estate Fund 5. This will make the fund an investor in one of Tallinn’s largest shopping centers – Kristiine Keskus. The center’s...

Continue reading

Volt Lithium Successfully Closes Second and Final Tranche of Non-Brokered Private Placement

Not for distribution to U.S. newswire services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. securities law. CALGARY, Alberta, Nov. 28, 2024 (GLOBE NEWSWIRE) — Volt Lithium Corp. (TSXV: VLT) (“Volt” or the “Company”) is pleased to announce that it has successfully closed the second and final tranche of its previously announced non-brokered private placement of units (“Units”) of the Company (the “Concurrent Private Placement”). The Company completed the second tranche of the Concurrent Private Placement by distributing 430,645 Units at a price of $0.31 per Unit for gross proceeds of approximately $134,000. Together with the first tranche of the Concurrent Private Placement, the Company issued an aggregate of 1,559,254 Units for aggregate gross proceeds...

Continue reading

Rakovina Therapeutics Announces Increase in Private Placement Offering to $2.5 Million

VANCOUVER, British Columbia, Nov. 28, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies is pleased to announce that, in response to investor demand, the Company intends to increase the size of the previously announced $1.25 million non-brokered private placement (the “Offering”) to $2.5 million. The Offering is structured as units priced at $0.06 each, with each unit consisting of one common share and one warrant to purchase a common share. Each warrant entitles the holder to purchase one additional common share at a price of $0.10 per share, exercisable for a period of 24 months. Rakovina retains the right to accelerate the warrant exercise period if the...

Continue reading

Western Forest Products and United Steelworkers Reach Tentative Collective Agreement

VANCOUVER, British Columbia, Nov. 28, 2024 (GLOBE NEWSWIRE) — Western Forest Products Inc. (TSX: WEF) (“Western” or the “Company”) announced today that the Company and the United Steelworkers Local 1-1937 (“USW”) have agreed to the terms of a tentative collective agreement. The USW represents approximately 1,000 Western employees. The tentative agreement is subject to a ratification vote by USW membership, which is expected to occur before the end of the year. The USW bargaining committee has advised that they will be recommending that its members accept this agreement. “This tentative agreement is the result of the professional and principled work of the bargaining team members from both the USW and Western, who worked respectfully to find common ground and solutions that support both employees and the business,” said Steven Hofer,...

Continue reading

Laurent-Perrier : Financial press release – Results for the first six months of the 2024-2025 financial year

Laurent-Perrier Group        Tours-sur-Marne, 29 November 2024 Financial press releaseResults for the first six months of the 2024-2025 financial year Laurent-Perrier: Half-year results down,maintained high level of profitability The financial statements for the first six months of the 2024-2025 financial year to 30 September 2024, were approved by the Management Board on 26 November 2024 and examined on the same day by the Supervisory Board, chaired by Mr Patrick THOMAS. The main consolidated financial data:In millions of EurosAt 30 September 2024 1st 6 monthsFinancial Year2023-2024(1 April 2023 –30 September 2023) 1st 6 monthsFinancial Year2024-2025(1 April 2024 –30 September 2024) Change vs FY N-1Champagne sales 153.4 128.8 -16.0%Group turnover 158.4 132.0 -16.7%Operating income 57.4 38.8 -32.4%Operating margin...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.